Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 16 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

56%

9 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed trials have results

Key Signals

6 recruiting1 with results

Enrollment Performance

Analytics

Phase 3
7(50.0%)
Phase 1
3(21.4%)
Phase 2
2(14.3%)
Phase 4
2(14.3%)
14Total
Phase 3(7)
Phase 1(3)
Phase 2(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT01733082Recruiting

The Mycophenolate Pregnancy Registry

Role: collaborator

NCT06467201Phase 1Completed

SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of AMN1126 in Healthy Post-Menopausal Females

Role: lead

NCT07138560Phase 4Recruiting

BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease

Role: collaborator

NCT06765668Phase 4Recruiting

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Role: collaborator

NCT00404989Recruiting

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.

Role: collaborator

NCT06267274Phase 1Recruiting

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

Role: lead

NCT05401357Phase 3Recruiting

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

Role: lead

NCT02121002Phase 3Completed

Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the Knee

Role: lead

NCT02940561Phase 1Unknown

BE Study in Patients - Methotrexate Tablets

Role: lead

NCT02125253Phase 3Completed

Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Role: lead

NCT02103322Phase 2Completed

Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions

Role: lead

NCT02072954Phase 2Completed

Bioequivalence Fasting Study in Patients

Role: lead

NCT01779947Phase 3Completed

Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo

Role: lead

NCT02110368Phase 3Completed

Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions

Role: lead

NCT01650051Phase 3Completed

Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)

Role: lead

NCT01064024Phase 3Completed

Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo

Role: lead

All 16 trials loaded